Foghorn Therapeutics (FHTX) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Foghorn Therapeutics (FHTX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 15, 2025 (21:59)

Sector: Healthcare

The share price of Foghorn Therapeutics Inc. (FHTX) now

Latest session on the 14th of May for
Foghorn Therapeutics Inc. is negative
Trading Volume: 77589
Open: 4.3 /  High: 4.516 /  Low: 4.085
Current value: $4.11
What analysts predict: $10.57
52-week High/Low: $4.605 / $3.565
50-Day Moving Average: $4.072 — support level today
200-Day Moving Average: $6.11 — resistance level today

Are you interested in Foghorn Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Foghorn Therapeutics stock price in 2025, 2026, 2027. How much will one Foghorn Therapeutics share be worth in 2025 - 2027?

When should I take profit in Foghorn Therapeutics stock? When should I record a loss on Foghorn Therapeutics stock? What are analysts' forecasts for Foghorn Therapeutics stock? What is the future of Foghorn Therapeutics stock? We forecast Foghorn Therapeutics stock performance using neural networks based on historical data on Foghorn Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Foghorn Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Foghorn Therapeutics shares. This happens once a day.


Historical and forecast chart of Foghorn Therapeutics stock

The chart below shows the historical price of Foghorn Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Foghorn Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Foghorn Therapeutics Inc. focuses on the discovery and development of drugs targeting genetically determined addictions in the chromatin regulatory system. The Company’s gene traffic management platform enables it to identify, validate and potentially use drug targets in the chromatin regulatory system. It is initially focused on oncology. The company is developing FHD-286, a selective allosteric ATPase inhibitor, and FHD-609, a protein breaker, for the treatment of hematologic cancers and solid tumors. FHD-286 is an allosteric and orally available, small molecule, enzymatic inhibitor of BRG1 and BRM, which is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein breaker BRD9. The company is also developing complementary programs for large populations, which include selective BRM and selective ARID1B modulators.

Trending Themes in the Healthcare Sector

Foghorn Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 17 4.30 4.19 4.34 3.49
May 18 4.28 4.18 4.35 4.02
May 19 4.35 4.29 4.42 3.17
May 20 4.22 4.15 4.27 2.89
May 21 4.34 4.30 4.46 3.67
May 22 4.41 4.30 4.46 3.78
May 23 4.42 4.35 4.50 3.45
May 24 4.39 4.35 4.50 3.39
May 25 4.40 4.29 4.51 5.17
May 26 4.39 4.27 4.44 4.07
May 27 4.42 4.33 4.46 3.07
May 28 4.55 4.51 4.65 3.19
May 29 4.54 4.41 4.59 4.08
May 30 4.58 4.52 4.73 4.46
May 31 4.52 4.38 4.65 6.20
Jun 01 4.54 4.45 4.62 3.71
Jun 02 4.68 4.58 4.81 5.03
Jun 03 4.70 4.60 4.76 3.35
Jun 04 4.68 4.54 4.80 5.81
Jun 05 4.72 4.62 4.85 5.11
Jun 06 4.73 4.68 4.77 2.11
Jun 07 4.67 4.53 4.72 4.13
Jun 08 4.67 4.61 4.75 3.00
Jun 09 4.59 4.49 4.71 4.78
Jun 10 4.51 4.45 4.56 2.44
Jun 11 4.49 4.35 4.57 4.87
Jun 12 4.31 4.22 4.43 4.90
Jun 13 4.37 4.28 4.46 4.37
Jun 14 4.45 4.33 4.51 4.27
Jun 15 4.51 4.44 4.64 4.35

Foghorn Therapeutics Daily Price Targets


Foghorn Therapeutics Stock Forecast 05-17-2025.

Forecast target price for 05-17-2025: $4.30.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.373%.
Pessimistic target level: 4.19
Optimistic target level: 4.34

Foghorn Therapeutics Stock Forecast 05-18-2025.

Forecast target price for 05-18-2025: $4.28.
Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.864%.
Pessimistic target level: 4.18
Optimistic target level: 4.35

Foghorn Therapeutics Stock Forecast 05-19-2025.

Forecast target price for 05-19-2025: $4.35.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.071%.
Pessimistic target level: 4.29
Optimistic target level: 4.42

Foghorn Therapeutics Stock Forecast 05-20-2025.

Forecast target price for 05-20-2025: $4.22.
Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 2.806%.
Pessimistic target level: 4.15
Optimistic target level: 4.27

Foghorn Therapeutics Stock Forecast 05-21-2025.

Forecast target price for 05-21-2025: $4.34.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.540%.
Pessimistic target level: 4.30
Optimistic target level: 4.46

Foghorn Therapeutics Stock Forecast 05-22-2025.

Forecast target price for 05-22-2025: $4.41.
Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.644%.
Pessimistic target level: 4.30
Optimistic target level: 4.46

FHTX (FHTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 4.83 3.97 6.29 36.85
Jul. 6.17 5.36 7.10 24.51
Aug. 6.26 4.99 6.94 27.99
Sep. 4.64 3.46 5.77 40.04
Oct. 4.66 3.81 6.20 38.55
Nov. 3.65 3.16 4.70 32.87
Dec. 4.56 4.14 6.07 31.83

Foghorn Therapeutics forecast for this year


Foghorn Therapeutics Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $4.83168. Pessimistic: $3.97. Optimistic: $6.29


Foghorn Therapeutics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $6.1715. Pessimistic: $5.36. Optimistic: $7.10


Foghorn Therapeutics Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $6.25852. Pessimistic: $4.99. Optimistic: $6.94


Foghorn Therapeutics Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $4.6407. Pessimistic: $3.46. Optimistic: $5.77


Foghorn Therapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $4.66251. Pessimistic: $3.81. Optimistic: $6.20


Foghorn Therapeutics Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $3.65447. Pessimistic: $3.16. Optimistic: $4.70


Foghorn Therapeutics Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $4.5648. Pessimistic: $4.14. Optimistic: $6.07



Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 4.16 3.08 5.19 40.64
Feb 4.04 3.51 5.56 36.89
Mar 3.36 2.71 3.86 29.82
Apr 3.85 3.36 4.79 29.84
May 2.54 2.16 3.36 35.62
Jun 2.74 2.41 3.25 25.72
Jul 2.76 2.18 3.42 36.40
Aug 3.71 2.71 4.32 37.13
Sep 3.95 3.08 4.71 34.68
Oct 3.27 2.68 4.16 35.46
Nov 2.85 1.85 3.59 48.55
Dec 3.74 2.63 4.70 44.07

Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 3.75 3.17 4.30 26.25
Feb 2.29 1.55 2.60 40.54
Mar 2.22 1.48 2.83 47.64
Apr 1.40 1.02 1.73 40.95
May 1.31 0.95 1.47 35.60
Jun 1.70 1.12 1.98 43.41
Jul 2.47 1.70 3.16 46.19
Aug 3.04 2.45 3.74 34.38
Sep 1.82 1.27 2.17 41.54
Oct 2.12 1.54 2.44 37.03
Nov 2.57 2.31 3.21 28.22
Dec 2.61 2.03 3.25 37.39

Foghorn Therapeutics information and performance

Foghorn Therapeutics Address

500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US

Market Capitalization: 234 029 000 $

Market capitalization of the Foghorn Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FHTX shares in the company outstanding by the market price of one share.

EBITDA: -97 165 000 $

EBITDA of Foghorn Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.58

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.505
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.213

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.214

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 55721000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Foghorn Therapeutics Stock)

Should I Buy Foghorn Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $4.16, which is $0.05 higher than the current stock price. By investing in Foghorn Therapeutics shares today for a one-year period, you could achieve a profit of 1.15%. With an investment horizon of up to two years, the target share price is 3.75$. Убыток: 8.69% (-0.36$ на каждую акцию).

Does Foghorn Therapeutics pay dividends?

No, it does not

Which economic sector do Foghorn Therapeutics's shares belong to?

Foghorn Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Foghorn Therapeutics's shares?

You can view all the stocks that are part of the same sector as Foghorn Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.